Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Tapeworms: Genome Mapped

14.03.2013
For the first time, scientists have mapped the entire genome of four tapeworm species. Their publication in "Nature" magazine reveals new weak spots of the parasites – they seem to be susceptible to standard cancer drugs.

Tapeworms live in the intestines and absorb nutrients from their hosts without doing any major harm. Their larvae, in contrast, are much more dangerous. They can migrate to the liver, lung, brain or other organs and form cysts in these tissues which can grow to the size of a handball. These cysts can have severe consequences for the infected persons, such as blindness, epilepsy, liver failure and even death.


In this stage, the larva of a fox tapeworm enters the fox that has eaten an infected mouse. In the centre of the globular structure, we can see more clear-cut bends: This is the set of hooks the tapeworm uses to attach to the intestinal wall of the fox. (Photo: Klaus Brehm)


Fox tapeworm kept in the lab: The larval stages are cultivated in the lab. In the liver of the intermediate hosts they grow like a tumor. This system was developed at Würzburg University. It allows testing which drugs kill the parasite, among others. (Photo: Klaus Brehm)

Professor Klaus Brehm of the University of Würzburg estimates that several hundred million people worldwide are infected by tapeworms – especially in the tropics, and especially in regions where people live closely together with animals under poor hygienic conditions. According to Brehm, no therapy is presently available that reliably kills the dangerous tapeworm larvae.

Fascinating results in "Nature"

Against this background, an international research team has now presented fascinating new insights into tapeworms in the top science magazine "Nature". Besides scientists from England and Mexico, a team of the University of Würzburg has been a major contributor to the study: Klaus Brehm and his associates Ferenc Kiss and Uriel Kozial of the Institute for Hygiene and Microbiology.

The researchers have sequenced the genome of fox tapeworm, pork tapeworm, dog tapeworm and dwarf tapeworm for the first time. "The DNA sequences now help us find potential drug targets on which therapies can act", says Dr Matthew Berriman of the Sanger Institute in Hinxton near Cambridge (England). Normally, researchers identify new targets for drugs to combat diseases by comparing a pathogen's genome sequence with the human host's DNA to find differences between them. This time, however, researchers deliberately looked for similarities: They wanted to identify new targets for drugs which have already proved effective in other conditions.

Cancer drugs to fight tapeworms

A list of the most promising targets shows: Many are identical to targets on which cancer treatments take effect. The reason: "A tapeworm infection takes a course much like the growth of a tumour", Brehm explains. "The larvae of the fox tapeworm, for instance, metastasise and proliferate in the whole body." Additionally, their development is controlled by the same genes responsible for the growth of a cancer cell. The larvae are therefore probably susceptible to standard cancer treatments.

Proteins as possible targets

But the researchers uncovered even more weak spots of the parasites. In the course of evolution, tapeworms have lost the ability to synthesise the necessary fats and cholesterol that are crucial for larvae development. Instead, they scavenge from their hosts. They use proteins to bind the necessary fats. By attacking these proteins with certain drugs, researchers hope to "starve" the larvae.

Tests on cell cultures of tapeworms

But are the identified new targets really weak spots of the tapeworms? This is currently being studied at the University of Würzburg. Klaus Brehm and his team have done pioneering work here to develop methods to cultivate the cells of fox tapeworm in the laboratory. "This enables us to test the potential drugs and select the most effective ones for further studies."

Reason for failure discovered

The genome analysis has shown why treatment attempts so far have been unsuccessful. The drug Praziquantel, for instance, which blocks certain calcium channels, had been used to combat the tapeworm larvae. It reliably kills the tapeworm species living in the intestines, but is ineffective against larvae – because said channels hardly exist in the larvae, as has been discovered recently.

Fascination tapeworm

Klaus Brehm and his team at the University of Würzburg study other aspects of tapeworms which might be important for medical progress.

"The tapeworm larvae behave like perfect transplants", the Würzburg scientist explains. "They implant themselves in the liver, for example, where they grow over years without the immune system noticing". If scientists knew how this perfect camouflage against the immune system works, major advances could be achieved in organ transplantation. Because transplanted organs are frequently rejected by the recipient's immune system.

Brehm is also fascinated by another characteristic of the parasites: "A tapeworm is theoretically immortal". How is that possible? The tapeworms fertilise themselves in their final host's intestine and their eggs pass into the environment with the host's faeces. The eggs are eaten by the intermediate hosts, transform into larvae and end up in the final host again – an endless cycle. "We want to learn how that works", Brehm says. The genome analysis has already yielded one new finding for the Würzburg scientists: "Tapeworms have a very special stem cell system which we will continue to study now".

“The genomes of four tapeworm species reveal adaptations to parasitism”, Nature, March 13, 2013, DOI: 10.1038/nature12031

Contact

Prof. Dr. Klaus Brehm, Institut für Hygiene und Mikrobiologie, Universität Würzburg, phone +49(0)931) 31-46168, kbrehm@hygiene.uni-wuerzburg.de

Robert Emmerich | Uni Würzburg
Further information:
http://www.uni-wuerzburg.de

More articles from Life Sciences:

nachricht Closing the carbon loop
08.12.2016 | University of Pittsburgh

nachricht Newly discovered bacteria-binding protein in the intestine
08.12.2016 | University of Gothenburg

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Closing the carbon loop

08.12.2016 | Life Sciences

Applicability of dynamic facilitation theory to binary hard disk systems

08.12.2016 | Physics and Astronomy

Scientists track chemical and structural evolution of catalytic nanoparticles in 3-D

08.12.2016 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>